DaVita HealthCare Partners Aktie News

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.

Although former Berkshire Hathaway (NYSE:BRK-B) CEO Warren Buffett retired as the company's chief executive, his legacy looms large.

Shares of kidney dialysis treatment company DaVita understandably struggled in 2025. Its most recent quarterly report and guidance for the year ahead, however, were both better than anticipated.

DaVita (DVA) delivered a strong earnings beat, driving a 13.5%+ share price surge and reinforcing my positive outlook. DVA's strategy leverages home dialysis, integrated kidney care, and international expansion, supporting double-digit growth and margin stability despite sector headwinds. I maintain a fair value of $185/share and a price target of $130/share, reiterating a 'BUY' rating even aft...

DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript

DaVita projected annual profit above estimates on Monday after reporting better-than-expected fourth-quarter results on steady demand for its kidney dialysis services, sending its shares up 13% in after-hours trading.

DENVER, Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2025. "Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial targets we set out at the beginning of the year despite a challenging environment," said Javier Rodriguez, CE...

Buying a stock is easy, but buying the right stock without a good strategy is incredibly hard. Here are five top-performing stocks to buy now or put on a watchlist.